|
|
Home > Healthcare > Pharmaceutical > General Pharmaceutical
Slovakia Pharmaceuticals and Healthcare Report Q3 2009
|
|
- Executive Summary
- SWOT Analysis
- Slovakia Pharmaceuticals Industry SWOT
- Slovakia Political SWOT
- Slovakia Economic SWOT
- Slovakia Business Environment SWOT
- Pharmaceutical Business Environment Ratings
- Table: Regional Pharmaceutical Business Environment Ratings Q309
- Limits Of Potential Returns
- Risks To Realisation Of Returns
- Slovakia - Market Summary
- Regulatory Regime
- Generics Legislation
- Recent Regulatory Developments
- Intellectual Property Regime
- IP Deficiencies
- Pricing Regime
- Reimbursement Regime
- Pricing Developments
- Eurozone Entry
- Table: Slovakia - Exchange Rate Policy
- Industry Trends And Developments
- Epidemiology
- Table: Main Causes Of Mortality And Morbidity In Slovakia, 2006
- Table: Disease Burden In CEE
- Healthcare Sector
- Healthcare Sector Reforms
- Health Insurance
- Recent Health Insurance Developments
- Healthcare Funding Crisis
- Regional Healthcare Sector Developments
- Pharmaceutical Industry
- Recent Pharmaceutical Industry Developments
- Research And Development
- Industry Forecast Scenario
- Overall Market Forecast
- Table: Slovakia - Drug Expenditure Indicators, 2004-2013
- Key Growth Factors - Industry
- Table: Slovakia - Health Market Indicators, 2004-2013
- Key Growth Factors - Macroeconomic
- Table: Slovakia - Economic Activity, 2006-2013
- Prescription Market Forecast
- Table: Slovakia - Prescription Market Indicators, 2004-2013 (US$mn unless otherwise stated)
- OTC Market Forecast
- Table: Slovakia - OTC Market Indicators, 2004-2013 (US$mn unless otherwise stated)
- Patented Market Forecast
- Table: Slovakia - Patented Market Indicators, 2004-2013
- Generic Drug Market Forecast
- Table: Slovakia - Generic Market Indicators, 2004-2013
- Export/Import Forecasts
- Table: Slovakia - Pharmaceutical Trade Indicators, 2004-2013
- Medical Devices Forecast
- Table: EU Medical Device Classifications
- Table: Slovakia Medical Device Market Forecast , 2004 - 2012
- Other Healthcare Data Forecasts
- Table: Slovakia - Other Healthcare Indicators, 2004-2013
- Key Risks To BMI’s Forecast Scenario
- Competitive Landscape
- Company Monitor
- Multinational Company Profiles
- GlaxoSmithKline (GSK)
- Sanofi-Aventis
- Pfizer
- Novartis
- Merck & Co
- Roche
- Indigenous Company Profiles
- Zentiva (incorporating Sicomed)
- Biotika
- Hoechst-Biotika
- Imuna Pharma
- Country Snapshot: Slovakia Demographic Data
- Section 1: Population:
- Table: Demographic Indicators
- Table: Rural/Urban Breakdown
- Section 2: Education & Healthcare
- Table: Education
- Table: Healthcare: Vital Statistics
- Section 3: Labour Market And Spending Power
- Table: Employment Indicators
- Table: Consumption And Stratification
- Table: Wages Per Year
- BMI Forecast Modelling
- How We Generate Our Pharmaceutical Industry Forecasts
- Pharmaceutical Business Environment Ratings Methodology
- Ratings Overview
- Table: Pharmaceutical Business Environment Indicators
- Weighting
- Table: Weighting Of Components
- Sources
|
Similar Products
• United States Type 2 Diabetes Market
Published Nov 2009 by Intellent
• Snapshots Poland Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Snapshots Venezuela Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Snapshots Spain Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Snapshots South Africa Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Snapshots Hungary Pharmaceuticals 2009
Published Nov 2009 by Snapdata International Group
• Nigeria Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
• Kenya Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
• Company Financials: Bayer AG
Published Nov 2009 by Datamonitor
• Merck & Co. Performance, Products, Pipeline and Potential
Published Nov 2009 by Espicom Healthcare Intelligence
|
|
|
|
0 items
